By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ajinomoto Althea Inc. 

11040 Roselle Street

San Diego  California  92121  U.S.A.
Phone: 858-882-0123 Fax: 858-882-0133


Ajinomoto Althea, located in San Diego, CA, is a contract development and manufacturing organization that specializes in cGMP manufacturing, analytical development, aseptic filling into vials & syringes, and protein delivery technology for recombinant protein and parenteral products. In a single location, Althea has the capacity to meet your early-stage and commercial requirements.

Key Services:

• Cell Line Development
• Process Development
• cGMP Protein & DNA Plasmid Production
• Analytical Method Development
• Lyophilization Cycle Development
• Sterile Vial Filling
• Sterile Syringe Filling

Protein Formulation Technology - Crystalomics™

• High Concentration Formulations
• Sustained Release Formulations
• Proven Technology
• Proven cGMP Manufacturability at Scale

Since its founding in 1998, Althea's manufacturing facilities have been inspected by the FDA in 2005, 2008, 2011 (2), 2012 & 2013, and by over 30 different QPs. To-date, Althea’s cGMP facilities have produced >300 cell banks, >160 cGMP protein & plasmid DNA lots, and >1,700 cGMP fill & finish lots. Althea has the experience, expertise, capacity, and flexibility to serve as your strategic partner for your drug development and manufacturing needs.

Key Statistics

Ownership: Private

Web Site: Ajinomoto Althea Inc.

Company News
Ajinomoto Althea Inc. Opens Manufacturing Suites In New High Potency And Antibody Drug Conjugate Commercial Facility 9/19/2017 7:00:35 AM
Ajinomoto Althea Inc. Announces New Aseptic Fill Finish Line 8/24/2017 10:47:39 AM
Ajinomoto Althea Inc. CEO David Enloe Awarded "Most Admired CEO" 7/6/2017 8:07:18 AM
Biologics Candidate Manufactured Using Ajinomoto Althea Inc.'s CORYNEX Protein Expression System Enters Clinical Trials For The First Time 10/4/2016 8:14:02 AM
Ajinomoto Althea Inc. Announces Issuance Of New US Patent For Manufacturing Of Crystal Monoclonal Antibodies 5/17/2016 6:34:50 AM
Ajinomoto Althea Inc. Expands Its Capacity Of Fill Finish Manufacturing With Addition Of Second Shift 3/15/2016 8:50:00 AM
Ajinomoto Althea Inc. Launches Process And Analytical Development Services For Antibody Drug Conjugates (ADCs) Therapeutics 12/10/2015 8:31:03 AM
Ajinomoto Althea Inc. Receives European GMP Certification For Commercial Aseptic Filling And Testing 6/16/2015 9:09:24 AM
Ajinomoto Completes Acquisition of Althea Technologies, Inc. 4/5/2013 9:00:05 AM
Ajinomoto Agrees to Acquire Althea Technologies, Inc. for $175 Million 3/6/2013 7:37:04 AM